Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term management of atopic hand eczema with Elidel cream 1% (pimecrolimus)
2005-003644-59Phase 4Active
- Sponsor
- Heidelberg University
- Start
- Aug 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of pimecrolimus in atopic dermatitis (AD) (2 arms), sponsored by Heidelberg University. Primary endpoint: Time to relapse after flare control. Started Aug 2006; status: active.
02
Drugs
pimecrolimus
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2005-003644-59.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003644-59.